SQZ ® eAPC Platform Demonstrates that mRNA-based Expression of Co-Stimulatory CD86 and Membrane-bound IL-2 and IL-12 Dramatically Increases Antigen-Specific CD8 T Cell Activity T Cell Responses Shown ...
Health care, heavy industry, wind, and award winning design are just a few of the many areas in which EAPC Architects Engineers excel. Since 1967, EAPC has continually expanded its services designing ...
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies Company (NYSE: SQZ) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for the company’s ...
EAPC Architects Engineers is pleased to announce the addition of four new hires to its team. Leonard "Red" Schaff, PE has joined as Senior ...